Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

79.48 -2.61 (-3.19%)

Streaming Delayed Price Updated: 3:40 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗

March 15, 2026

This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.

Via The Motley Fool

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗

March 15, 2026

RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.

Via The Motley Fool

Friday's session: top gainers and losers in the S&P500 index ↗

March 13, 2026

Via Chartmill

Edwards Lifesciences Corp (NYSE:EW) Reports Mixed Q4 Results, Misses EPS Estimates ↗

February 10, 2026

Via Chartmill

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗

February 20, 2026

Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s...

Via The Motley Fool

Topics Regulatory Compliance

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...

Via MarketMinute

Exploring the top movers within the S&P500 index during today's session. ↗

February 17, 2026

Via Chartmill

The Return of the Mega-Deal: How 2026’s Regulatory Pragmatism is Reshaping Corporate America

February 13, 2026

The U.S. mergers and acquisitions (M&A) landscape has entered a definitive new era in early 2026, marked by what analysts are calling a "Strategic Rebound." After years of aggressive antitrust...

Via MarketMinute

Topics Artificial Intelligence Economy

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗

February 12, 2026

Via MarketBeat

Unusual volume S&P500 stocks in Wednesday's session ↗

February 11, 2026

Via Chartmill

Edwards Lifesciences (EW) Earnings Transcript ↗

February 10, 2026

Edwards Lifesciences (EW) Earnings Transcript

Via The Motley Fool

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

January 27, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)...

Via MarketMinute

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗

January 25, 2026

Via MarketBeat

The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare

January 23, 2026

The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy

The Death of the Quick Deal: One Year Under the New FTC and DOJ Merger Regime

January 23, 2026

As we enter the early weeks of 2026, the American corporate landscape is still adjusting to a fundamental shift in the mechanics of growth. It has been nearly one year since the most significant...

Via MarketMinute

Topics Economy

The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition

January 15, 2026

MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence

BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era

January 02, 2026

As the financial markets open for the 2026 calendar year, BTIG has released its highly anticipated "Top Picks" report for the first half of the year, signaling a transition from the speculative fervor...

Via MarketMinute

Topics Artificial Intelligence Economy

The 2025 Dollar Rollercoaster: A Year-End Rally Masks a Historic Annual Retreat

December 31, 2025

As the final trading bells of 2025 ring out across Wall Street, the US Dollar is staging a defiant last-minute stand. After a year defined by dizzying volatility—ranging from a massive early-year surge...

Via MarketMinute

Topics Economy World Trade

Edwards Lifesciences Corp (NYSE:EW) Shows Strong Technical Setup for Potential Breakout ↗

December 26, 2025

Edwards Lifesciences (EW) shows strong technicals and a high-quality consolidation pattern, suggesting a potential breakout trade setup for chart-focused investors.

Via Chartmill

Discover which S&P500 stocks are making waves on Tuesday. ↗

December 16, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Edwards Lifesciences (EW) Earnings Transcript ↗

November 27, 2025

Edwards Lifesciences (EW) Earnings Transcript

Via The Motley Fool

EDWARDS LIFESCIENCES CORP (NYSE:EW) Shows Strong Technicals and a High-Quality Breakout Setup ↗

November 27, 2025

Edwards Lifesciences (EW) stock shows strong technical momentum and a high-quality breakout setup, poised for a potential move above key resistance.

Via Chartmill

Goodbye Nvidia, Hello Microsoft: Halvorsen's Big Q3 Hedge Fund Pivot ↗

November 17, 2025

Andreas Halvorsen of Viking Global Investors' portfolio Q3 changes included exits from Amazon, Nvidia and Qualcomm.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 11, 2025

Via Benzinga

Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today ↗

November 04, 2025

Via Benzinga

Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday? ↗

October 31, 2025

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.

Via Benzinga

EDWARDS LIFESCIENCES CORP (NYSE:EW) Beats Q3 Estimates and Raises Full-Year Guidance ↗

October 30, 2025

Edwards Lifesciences beats Q3 earnings, raises full-year guidance on strong structural heart portfolio growth and robust TAVR & TMTT sales.

Via Chartmill

Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance ↗

October 30, 2025

Edwards Lifesciences stock jumped late Thursday after the medtech company boosted its 2025 outlook after beating quarterly calls.

Via Investor's Business Daily

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.